Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Production and immunogenicity of chimaeric human papillomavirus-like particle vaccines

Includes bibliographical references (leaves 129-146).

Saved in:
Bibliographic Details
Main Author: Burger, Marieta
Other Authors: Rybicki, Ed
Format: Thesis
Language:English
Published: Department of Molecular and Cell Biology 2015
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613289726345217
access_status_str Open Access
author Burger, Marieta
author2 Rybicki, Ed
author_browse Burger, Marieta
Rybicki, Ed
author_facet Rybicki, Ed
Burger, Marieta
author_sort Burger, Marieta
collection Thesis
description Includes bibliographical references (leaves 129-146).
format Thesis
id oai:open.uct.ac.za:11427/12377
institution University of Cape Town (South Africa)
language eng
last_indexed 2026-06-10T12:33:45.686Z
license_str Not specified — see source repository
provenance_str_mv Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository
publishDate 2015
publishDateRange 2015
publishDateSort 2015
publisher Department of Molecular and Cell Biology
publisherStr Department of Molecular and Cell Biology
record_format dspace
source_str UCTD — University of Cape Town Open Access Repository
spelling oai:open.uct.ac.za:11427/12377 Production and immunogenicity of chimaeric human papillomavirus-like particle vaccines Burger, Marieta Rybicki, Ed Hitzeroth, Inga Molecular and Cell Biology Includes bibliographical references (leaves 129-146). Human papillomavirus (HPV) infection, specifically with oncogenic types, has been implicated in effectively all cervical cancer cases. Cervical cancer is a global health burden, especially in the developing world. Up to 18 types of HPV are considered oncogenic, of which HPV -16 and -18 cause 70% of cervical cancer cases worldwide. Two vaccines are available on the market: Gardasil(R), targeted against HPV -16, -18; -6 and -11, and Cervarix(TM), against -16 and -18. Both vaccines are based on the L1 capsid proteins of the types they are targeted to and are efficient, pro- phylactic, typespecific vaccines. However, two problems remain: they do not protect against nonvaccine types, that may cause a significant proportion of cancers specifically in African and HIV- positive populations, and they cannot be used to treat existing infections. We designed eight different chimaeric vaccines. 2015-02-04T19:14:50Z 2015-02-04T19:14:50Z 2010 Master Thesis Masters MSc http://hdl.handle.net/11427/12377 eng application/pdf Department of Molecular and Cell Biology Faculty of Science University of Cape Town
spellingShingle Molecular and Cell Biology
Burger, Marieta
Production and immunogenicity of chimaeric human papillomavirus-like particle vaccines
thesis_degree_str Master's
title Production and immunogenicity of chimaeric human papillomavirus-like particle vaccines
title_full Production and immunogenicity of chimaeric human papillomavirus-like particle vaccines
title_fullStr Production and immunogenicity of chimaeric human papillomavirus-like particle vaccines
title_full_unstemmed Production and immunogenicity of chimaeric human papillomavirus-like particle vaccines
title_short Production and immunogenicity of chimaeric human papillomavirus-like particle vaccines
title_sort production and immunogenicity of chimaeric human papillomavirus like particle vaccines
topic Molecular and Cell Biology
url http://hdl.handle.net/11427/12377
work_keys_str_mv AT burgermarieta productionandimmunogenicityofchimaerichumanpapillomaviruslikeparticlevaccines